FDA approves Seattle Genetics cancer drug (Reuters)
Reuters – U. S. drug regulators on Friday approved a blood cancer medicine by Seattle Genetics Inc, making it the first drug for Hodgkin’s lymphoma approved since 1977.
View full post on Yahoo! News: Health News
Leave a Reply